NCT01660841View on ClinicalTrials.gov

Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging

PHASE3CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Magnetic Resonance Imaging
Interventions
DRUG

Gadobutrol (Gadovist, BAY86-4875)

A single bolus injection of gadobutrol 1.0M 0.1mmol/kg body weight.

Trial Locations (15)

455-8530

Nagoya

274-8503

Funabashi

810-0001

Fukuoka

811-0213

Fukuoka

800-0057

Kitakyushu

720-0825

Fukuyama

650-0047

Kobe

654-0047

Kobe

251-8550

Fujisawa

210-0013

Kawasaki

226-0025

Yokohama

574-0074

Daitō

596-8522

Kishiwada

750-0061

Shimonoseki

755-0151

Ube

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY